Menu Search
Equities

CorVel Corp

CRVL:NSQ

CorVel Corp

Actions
Health CareHealth Care Providers
  • Price (USD)358.99
  • Today's Change5.85 / 1.66%
  • Shares traded78.35k
  • 1 Year change+82.19%
  • Beta1.1324
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year CorVel Corp grew revenues 10.68% from 718.56m to 795.31m while net income improved 14.90% from 66.37m to 76.25m.
Gross margin21.81%
Net profit margin9.64%
Operating margin12.02%
Return on assets17.11%
Return on equity32.26%
Return on investment29.47%
More ▼

Cash flow in USDView more

In 2024, CorVel Corp increased its cash reserves by 47.99%, or 34.23m. The company earned 99.24m from its operations for a Cash Flow Margin of 12.48%. In addition the company used 29.24m on investing activities and also paid 35.76m in financing cash flows.
Cash flow per share4.52
Price/Cash flow per share78.56
Book value per share16.51
Tangible book value per share14.04
More ▼

Balance sheet in USDView more

CorVel Corp uses little or no debt in its capital structure.
Current ratio1.71
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items increased 16.52%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
EPS growth(5 years)12.61
EPS (TTM) vs
TTM 1 year ago		9.60
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.